Page 5 - 2021年15期
P. 5

CHINA PHARMACY

                             Volume 32,Number 15,August 15,2021

                                                 Semimonthly
                                       Selected Table of Contents



        Synergy of Centralized Drug Volume-based Purchasing and Medical Insurance Negotiation Policy ……………
          …………………………………………………………… TAN Qingli,GUO Runyi,SUN Huilin,YU Dachuan(1793)
        Enlightenment of Continuing Education Curriculum and Implementation Management System for Licensed

          Pharmacists in the United States to China ………………………… JIANG Rong,DING Ruilin,SHAO Rong(1800)
        Improvement Effect and Its Mechanism of Active Components of Averrhoa carambola on High Glucose-induced
          Injury of H9c2 Myocardial Cell ……………………………………………………………………………………
          ……… GAO Yutong,WU Yani,CHEN Ming,ZHANG Xiaolin,WEI Xiusha,WEI Xiaojie,HUANG Renbin(1805)
        Protective Effect of Protocatechuic Aldehyde on Neurovascular Unit Homeostasis Damage in Rats after Cerebral
          Ischemia-reperfusion Injury …………… FENG Jin,XU Yaling,MENG Qingting,YAN Hanwen,HE Fangyan(1811)
        Visualization Analysis of the Literatures on Drug-induced Kidney Injury …………………………………………
          …………………………………… ZHAO Yuanxia,CHU Yaojuan,LU Xiaojing,SHI Xiangfen,DU Shuzhang(1818)
        Establishment of HPLC Fingerprints of Ethanol Extract of Dendrobium nobiles from Different Habitats and
          Spectrum Effect Relationship Study of Its Anti-inflammatory Effect ……………………………………………
          …………………………………………………………… FENG Yue,DUAN Feipeng,LI Yisheng,QIU Shuqi(1825)
        Effects of Water Extract from Carpesium cernuum on Proliferation,Metastasis and Invasion of Prostate Cancer
          PC3 Cells ………………………… LIU Bo,YU Jia,WANG Kun,YAN Chen,HUANG Lirong,LUO Heng(1830)

        Analysis of Antitussive Active Ingredients of Asplenium sampsoni ……………………… LI Jun,LIANG Xiao(1837)
        Quality Evaluation of Polygonum cuspidatum by UPLC Fingerprint and QAMS …………………………………
          ……………………………………………………………………………… LIANG Hui,PAN Xiaojun,YANG
          Wenhui,LYU Weisheng,LUO Yuqin,WU Jiaxuan,WEI Mei,CHENG Xueren,LAN Xiaoyong,LI Zhenyu(1842)
        Effect and Its Mechanism of Plantago asiatica Polysaccharide on the Proliferation,Migration and Invasion of
          Breast Cancer Cells ………………………………………………………………………………………………
          CHEN Gao,YANG Xiaoting,WANG Xi,JIN Zhan,ZHU Rui,GAN Chunchun,ZHOU Daotang,YAO Shuihong(1849)
        Simultaneous Determination of 7 Active Components in Mori Australis Cortex and Mori Cortex from Different
          Sources by HPLC …………………………………………………………………………………………………
          … LI Hailing,HUANG Yanping,CHEN Xubing,GU Wenchao,ZHOU You,ZHANG Dequan,ZHOU Nong(1854)
        Preparation and Quality Evaluation of Azelnidipine Enteric Solid Dispersion ……………………………………
          ……………………………………………… JIANG Ting,ZHENG Lingli,YUAN Mingyong,JIANG Xuehua(1862)
        Improvement Effects of Sanggenone C on Lipid Accumulation in FFA-induced Human Liver Cancer HepG2 Cells
          … XING Juling,LIU Fen,FENG Meng,HAO Mengjiao,HUANG Tianlai,ZHOU Xinxin,TANG Xiangjiang(1868)
        Data-mining of Adverse Drug Events Signals for Tocilizumab Based on US FAERS Database …………………
          …………………………………………………………… LUO Lin,ZHANG Jiaying,CHEN Li,LONG Enwu(1874)
        Effects of Compound Danshen Dripping Pills on Contrast-induced Nephropathy after Percutaneous Coronary

          Intervention and Patients’Prognosis ………… ZHANG Yamei,MA Yufeng,YANG Shicheng,LIU Yuanyuan(1880)
        Systematic Analysis of Economic Evaluation of Listed PD-1/PD-L1 Inhibitors in China …………………………
          ……………………………… MA Yue,ZHU Shengwen,SUN Lei,GUAN Xin,CHEN Pingyu,LI Hongchao(1885)
        Analysis of Medication Errors in Patients with Hyperuricemia/Gout Based on National Monitoring Network for
          Clinical Safe Drug Use ………………………… ZHANG Qingxia,ZHANG Yizhi,ZENG Yan,WANG Yuqin(1894)
   1   2   3   4   5   6   7   8   9   10